Retrospective Simplex High Viscosity (HV) Bone Cement Study
NCT ID: NCT05659329
Last Updated: 2026-01-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2016-04-25
2022-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Simplex High Viscosity Bone Cement in Primary Total Knee Arthroplasty
NCT02572310
A Prospective, Randomized Study Comparing Cemented and Cementless Total Knee Replacement
NCT01194817
Total Knee Replacement Using Simplex® or Cobalt™ Bone Cement
NCT00589485
Cemented vs. Cementless Unicompartmental Knee Arthroplasty
NCT05616884
Comparison of A Mobile-Bearing Total Knee System With A Fixed-Bearing Total Knee System In Cemented Total Knee Arthroplasty
NCT00589108
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-medicated Simplex HV
Retrospective observation of patients who have received a Triathlon Total Knee Replacement implanted with nonmedicated Simplex HV Bone Cement.
Simplex HV/Gentamicin Simplex HV bone cement
Simplex HV bone cement is a fast-setting acrylic resin for use in bone surgery.
Simplex HV bone cement with Gentamicin is a fast setting acrylic resin with addition of gentamicin sulfate for use in bone surgery.
Mixing two separate sterile components produces a ductile bone cement which, after hardening, fixes the implant and transfers stresses produced during movement evenly to the bone.
Gentamicin Simplex HV
Retrospective observation of patients who have received a Triathlon Total Knee Replacement implanted with Gentamicin Simplex HV Bone Cement.
Simplex HV/Gentamicin Simplex HV bone cement
Simplex HV bone cement is a fast-setting acrylic resin for use in bone surgery.
Simplex HV bone cement with Gentamicin is a fast setting acrylic resin with addition of gentamicin sulfate for use in bone surgery.
Mixing two separate sterile components produces a ductile bone cement which, after hardening, fixes the implant and transfers stresses produced during movement evenly to the bone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Simplex HV/Gentamicin Simplex HV bone cement
Simplex HV bone cement is a fast-setting acrylic resin for use in bone surgery.
Simplex HV bone cement with Gentamicin is a fast setting acrylic resin with addition of gentamicin sulfate for use in bone surgery.
Mixing two separate sterile components produces a ductile bone cement which, after hardening, fixes the implant and transfers stresses produced during movement evenly to the bone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have undergone primary Triathlon Total Knee Arthroplasty in which Simplex HV/Simplex HV Gentamicin was indicated for fixation and used on label
* Patients who have been followed for at least 24 months postoperatively
Exclusion Criteria
* Patients who have undergone bilateral Knee Arthroplasty
* Patients contraindicated for either the devices implanted, or the cement used, according to medical history review and instructions for use
* Patient has a cementless tibial baseplate.
* Patient has an active or suspected latent infection in or about the affected knee joint
* Patient has muscle loss or neuromuscular impairment in the affected limb that would create an unjustifiable risk
* Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days)
* Patient has a known hypersensitivity to any of the cements constituents or in patients with severe renal failure
* Patient is a prisoner
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stryker Orthopaedics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Toms, Prof.
Role: PRINCIPAL_INVESTIGATOR
PEOC Royal Devon & Exeter Hospital
Matthew Hepinstall, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Orthopedic Surgery NYU Langone Health
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
80
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.